| 臺大學術典藏 |
2021-05-21T11:40:30Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan Wei; DA-LIANG OU; Fu, Yu Hsuan; HWEI-FANG TIEN; HSIN-AN HOU; LIANG-IN LIN |
| 臺大學術典藏 |
2022-01-25T06:01:28Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; HWEI-FANG TIEN; Hou, Hsin-An; Lin, Liang-In |
| 臺大學術典藏 |
2021-07-06T01:53:04Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan-Wei; Ou, Da-Liang; Fu, Yu-Hsuan; Tien, Hwei-Fang; Hou, Hsin-An; LIANG-IN LIN |
| 國家衛生研究院 |
2025-01-21 |
Repurposing linezolid in conjunction with histone deacetylase inhibitor access in the realm of glioblastoma therapies
|
Chen, IC;Lin, HY;Liu, ZY;Cheng, WJ;Yeh, TY;Yang, WB;Tran, HY;Lai, MJ;Wang, CH;Kao, TY;Hung, CY;Huang, YL;Liou, KC;Hsieh, CM;Hsu, T;Liou, JP |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; PO-REN HSUEH; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.; Tien H.-F.;Tang J.-L.;Hsu C.-A.;Li C.-C.;Ko B.-S.;Yao M.;Wu S.-J.;PO-REN HSUEH;Lin C.-T. |
| 臺大學術典藏 |
2020-12-18T08:37:05Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F.; Yao M.; Wu S.-J.; PO-REN HSUEH; Lin C.-T.; Lin C.-T.;Po-Ren Hsueh;Wu S.-J.;Yao M.;Ko B.-S.;Li C.-C.;Hsu C.-A.;Tang J.-L.;Tien H.-F. |
| 臺大學術典藏 |
2021-01-04T12:12:20Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Tang J.-L.; HWEI-FANG TIEN; Li C.-C.; Hsu C.-A.; Ko B.-S.; Yao M.; Wu S.-J.; Lin C.-T.; Hsueh P.-R. |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Li C.-C.; Ko B.-S.; Yao M.; SHANG-JU WU; Hsueh P.-R.; Lin C.-T.; Hsu C.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2018 |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; MING YAO; Ko B.-S.; Li C.-C.; Hsu C.-A.; Tang J.-L.; Tien H.-F. |
| 國立成功大學 |
2023-01-14 |
Repurposing nitric oxide donating drugs in cancer therapy through immune modulation
|
Li;Chung-Yen;Anuraga;Gangga;Chang;Chih-Peng;Weng;Tzu-Yang;Hsu;Hui-Ping;Ta;Khoa, Hoang Dang;Su;Pei-Fang;Chiu;Pin-Hsuan;Yang;Shiang-Jie;Chen;Feng-Wei;Ye;Pei-Hsuan;Wang;Chih-Yang;Lai;Ming-Derg |
| 國立臺灣大學 |
2015 |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang, Wei-Ling; Hsu, Lih-Ching; Leu, Wohn-Jenn; Chen, Ching-Shih; Guh, Jih-Hwa; 許麗卿; 顧記華 |
| 臺大學術典藏 |
2018-09-10T15:26:46Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang, W.-L.;Hsu, L.-C.;Leu, W.-J.;Chen, C.-S.;Guh, J.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:35Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang W.-L.;Hsu L.-C.;Leu W.-J.;Chen C.-S.;Jih-Hwa Guh; Chang W.-L.; Hsu L.-C.; Leu W.-J.; Chen C.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-07-06T07:01:21Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang W.-L.; LIH-CHING HSU; Leu W.-J.; Chen C.-S.; Guh J.-H. |
| 國立臺灣大學 |
2015 |
Repurposing of Phentolamine as a Potential Anticancer Agent Against Human Castration-Resistant Prostate Cancer: A Central Role on Microtubule Stabilization and Mitochondrial Apoptosis Pathway
|
Ho, Chen-Hsun; Hsu, Jui-Ling; Liu, Shih-Ping; Hsu, Lih-Ching; Chang, Wei-Ling; Chao, Chuck C. -K.; Guh, Jih-Hwa; 劉詩彬; 許麗卿; 顧記華 |
| 臺大學術典藏 |
2021-01-29T03:17:19Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.;Hsu J.-L.;Shih-Ping Liu;Hsu L.-C.;Chang W.-L.;Chao C.C.-K.;Guh J.-H.; Ho C.-H.; Hsu J.-L.; SHIH-PING LIU; Hsu L.-C.; Chang W.-L.; Chao C.C.-K.; Guh J.-H. |
| 臺大學術典藏 |
2021-06-02T05:43:35Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; Hsu L.-C.; Chang W.-L.; Chao C.C.-K.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-07-06T07:01:22Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; LIH-CHING HSU; Chang W.-L.; Chao C.C.-K.; Guh J.-H. |
| 國家衛生研究院 |
2020-05-23 |
Repurposing old drugs as antiviral agents for coronaviruses
|
Yang, CW;Peng, TT;Hsu, HY;Lee, YZ;Wu, SH;Lin, WH;Ke, YY;Hsu, TA;Yeh, TK;Huang, WZ;Lin, JH;Sytwu, HK;Chen, CT;Lee, SJ |
| 國立成功大學 |
2021-02-2 |
Repurposing the Antiemetic Metoclopramide as an Antiviral Against Dengue Virus Infection in Neuronal Cells
|
Shen;Ting-Jing;Hanh;Thi, Vu;Nguyen;Quoc, Thai;Jhan;Ming-Kai;Ho;Min-Ru;Lin;Chiou-Feng |
| 臺大學術典藏 |
2020-01-02T07:26:30Z |
Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent
|
Ko, Hao-Tai;Hsu, Li-Hang;Yang, Sheng-Yung;Chen, Ying-Lien; Ko, Hao-Tai; Hsu, Li-Hang; Yang, Sheng-Yung; Chen, Ying-Lien; YING-LIEN CHEN |
| 國立成功大學 |
2023 |
Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2α/ATF4/CHOP and secretory autophagy pathways
|
Tran, Tran T.-H.;Kao, M.;Liu, H.-S.;Hong, Y.-R.;Su, Y.;Huang, C.-Y.F. |
| 國立政治大學 |
2010-04-02 |
Reputation as an External Incentive Mechanism in State
|
李軍林;李天有 |
| 國立成功大學 |
2019-01-15 |
Reputation auction games for cooperative communications over green wireless networks
|
Lin;Hui-Tang;Lin;Ying-You;Yan;Wei-Shun;Wu;Jie-Yuan |
| 淡江大學 |
2011-07 |
Reputation Concerns or Economic Dependence? Evidence from Threshold Regression Model
|
林芳綺; Lee, C. F.; Lin, H. C.; Lin, Y. C. |
| 淡江大學 |
2010-07 |
Reputation Concerns or Economic Dependence? Evidence from Threshold Regression Model
|
林芳綺; Lin, Y. C. |
| 大葉大學 |
2007-07 |
Reputation Effects on Convertible Bond Call Policies
|
Chen, Yu-Fen;Chen, Anlin;Liu, Victor W. |
| 大葉大學 |
2007-12-12 |
Reputation Effects on Corporate Financing Policies
|
Chen, Yu-Fen;Liu, Victor W. |
| 大葉大學 |
2004-07 |
Reputation Effects on the Decision to Go Public
|
Chen, Yu-Fen;Liu, Victor W.;Chiang, Su-Jane |
| 亞洲大學 |
2022-NA |
Reputation or Compensation Concerns of Director Board
|
簡智崇;Chien, Chih-Chung |
| 臺大學術典藏 |
2019-08-12T09:30:09Z |
Reputation Recuperated: Amelia Opie in the Mid-nineteenth Century
|
Yi-cheng Weng; Yi-cheng Weng |
| 國立政治大學 |
2016-01 |
Reputation Risk and its Relation with Financial Performance: Evidence of Life Insurance Companies
|
Chen, Tsai-Jyh; 陳彩稚 |
| 元智大學 |
2010-10 |
Reputation Stretching in Mutual Fund Starts
|
賴慧文; Chen, Hsuan-Chi |
| 元智大學 |
2009-04 |
Reputation Stretching in Mutual Fund Starts
|
賴慧文; Hsuan-Chi Chen |
| 臺大學術典藏 |
2018-09-10T18:06:55Z |
Reputation versus information: The delegation policy when the principal has reputational concerns
|
Tamada, Yasunari; Tsai, Tsung-Sheng; TSUNG-SHENG TSAI |
| 大葉大學 |
2008-12-06 |
Reputation, IPO Decisions and IPO Mispricing
|
Chen, Yu-Fen;Chiang, Su-Jane;Liu, Victor W. |
| 國立臺灣科技大學 |
2012 |
Request for Existing Experimental Datasets on Colour Emotion and Colour Harmony
|
Ou, Li-Chen |
| 淡江大學 |
2018-10-09 |
Request full-text Multiple Watermarking for Compressed Sensing with Robust Transmission Applications
|
Huang, Hsiang-Cheh;Chang, Feng-Cheng;Lu, Yuh-Yih;Pang, Yi-Hsin |
| 國立交通大學 |
2014-12-08T15:12:43Z |
Request Scheduling for Differentiated QoS at Website Gateway
|
Lin, Ying-Dar; Tien, Ching-Ming; Tsao, Shih-Chiang; Wen, Shuo-Yen; Lai, Yuan-Cheng |
| 國立交通大學 |
2014-12-08T15:24:39Z |
Request scheduling for differentiated QoS at website gateway
|
Tien, Ching-Ming; Wen, Shuo-Yen; Lin, Ying-Dar; Lai, Yuan-Cheng |
| 國立臺灣科技大學 |
2006 |
Request scheduling for differentiated QoS at Website gateway
|
Tien C.-M.; Wen S.-Y.; Lin Y.-D.; Lai Y.-C. |
| 國立臺灣科技大學 |
2008 |
Request Scheduling for Differentiated Web QoS at Website Gateways
|
Lin, Ying-Dar ;Tien, Ching-Ming ;Tsao, Shih-Chiang ;Wen, Shuo-Yen ;Lai, Yuan-Cheng |
| 大葉大學 |
2013-10-12 |
Request Speech Acts
|
Lin, Grace Hui Chin |
| 臺大學術典藏 |
2021-01-04T05:52:11Z |
REQUIEM WITH TWO RELATED MOTETS
|
Chen, Jen-Yen; Chen, Jen-Yen; JEN-YEN CHEN |
| 臺北醫學大學 |
2011 |
Requip 0.25mgtab 力必平 膜衣錠
|
藥劑部藥師 |
| 臺北醫學大學 |
2011 |
Requip 1mgtab 力必平 錠
|
藥劑部藥師 |
| 臺北醫學大學 |
2011 |
Requip PD 2mgtab 力必平持續性藥效膜衣錠
|
藥劑部藥師 |
| 國立臺灣科技大學 |
2012 |
Required shear elements for transfored reinforced concrete plane stress element
|
Pan, C.-P.;Wang, S.-H. |
| 國立交通大學 |
2014-12-08T15:07:43Z |
Requirement estimation for indirect workforce allocation in semiconductor manufacturing
|
Chien, Chen-Fu; Chen, Wen-Chih; Hsu, Shao-Chung |
